Pediatrix Medical Group, Inc.: financial statements

MDNYSEHealthcare · Services-Hospitals

Price

$31.89

November 16, 2026Market cap $2.5B

What Ploutos Investor adds for Pediatrix Medical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from 2016
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Financial statements

Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.

2023–2025 fiscal years

Click a line to see it on the chart.

Revenue

-2.0% a year over 2 years

Line202320242025Average a year
Revenue $2.0B$2.0B$1.9B-2.0%
Operating income $7.3M-$69M$209M+433.5%
Net income -$60M-$99M$165M
Earnings per share $0.73-$1.19$1.94+63.0%
Earnings per share, basic $0.73-$1.19$1.97+64.2%
Margins
Operating margin 0.4%-3.4%10.9%
Net margin -3.0%-4.9%8.6%

Financial statements

MD's revenue, profits and cash flows from 2016 to 2022, 7 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

By segment

Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.

  • 2023: Health Care Patient Service $1.7B, Hospitals Contracts $276M, Product And Service Other $2.6M
  • 2024: Health Care Patient Service $1.7B, Hospitals Contracts $287M, Product And Service Other $2.6M
  • 2025: Health Care Patient Service $1.6B, Hospitals Contracts $271M, Product And Service Other $12M
Product202320242025Share 2025
Health Care Patient Service$1.7B$1.7B$1.6B85%
Hospitals Contracts$276M$287M$271M14%
Product And Service Other$2.6M$2.6M$12M0.6%

By segment

MD's revenue by product line from 2016 to 2022, 7 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

From the XBRL of 12 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.

Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.

Debt and obligations

What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.

$41M Leases23.6% Effective tax rate

Leases

Dec 31, 2025

Operating leases

$37M

Finance leases

$3.4M

The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt. The filing

Goodwill by segment

Dec 31, 2025

Total goodwill

$1.3B

The company does not state its goodwill by segment, at December 31, 2025. The filing

From the statutory to the effective tax rate, 2025

Dec 31, 2025

Statutory rate

21.0%

Effective rate

23.6%

+2.6 pts

The company paid 23.6% in tax on its profit, 2.6 points above the US federal rate (21.0%). Below, the reasons it gives.

Statutory rate

21.0%

State and local taxes

+4.3 pts

Difference the filing does not itemize

-1.7 pts

Effective rate

23.6%

One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing

Earnings quality

How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.

Receivables and inventory against sales

In the quarter to Sep 30, 2026, sales were +1.7% on the same quarter a year earlier, and receivables +0.3%.

a year earlier 43 days
42 days

Balances at Sep 30, 2026 and Sep 30, 2025, against the sales and cost of sales of the quarter ending on each date; a fourth quarter is the fiscal year less its first nine months. Same quarter against same quarter, so the season is the same.

Taxes: deferred and paid

The deferred part was 102.2% of the tax charge in the year to Dec 31, 2025.

  • The deferred share is higher than at nine in ten S&P 500 companies.
Deferred share, year to Dec 31, 2025$52M of $51M
102.2%

When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.

The earnings per share split is not shown: it needs a profit before tax in both years, since a tax rate on a loss has no meaning as a source.

The allowance for doubtful accounts is not shown: the company does not tag it in its structured filings.

A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.

The full analysis

What do Pediatrix Medical's filings show?

These are Pediatrix Medical's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MD's financials

Didn't find what you were looking for?

Ask us
How much revenue did MD have in 2025?

Pediatrix Medical had revenue of $1.9B and net income of $165M in fiscal 2025, a net margin of 8.6%.

How much debt does MD have?

On December 31, 2025 Pediatrix Medical had total assets of $2.2B, debt of $597M and shareholders' equity of $866M.

How much free cash flow does MD have?

In fiscal 2025 Pediatrix Medical had cash from operations of $271M and spent $18M on capital expenditure, leaving $253M of free cash flow.

Where are the figures from?

From Pediatrix Medical Group, Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.